| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(199807)41:7<1152::AID-ART3>3.0.CO;2-L |
| P698 | PubMed publication ID | 9663470 |
| P2093 | author name string | Anderson P | |
| Utz PJ | |||
| P2860 | cites work | Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies | Q24564876 |
| Identification of an snRNP-associated kinase activity that phosphorylates arginine/serine rich domains typical of splicing factors | Q24633425 | ||
| Caspase Cleavage of Keratin 18 and Reorganization of Intermediate Filaments during Epithelial Cell Apoptosis | Q24683768 | ||
| Novel packages of viral and self-antigens are generated during apoptosis | Q27485110 | ||
| Caspase-3-mediated Cleavage of Protein Kinase C θ in Induction of Apoptosis | Q28245911 | ||
| Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity | Q28276063 | ||
| Human ICE/CED-3 protease nomenclature | Q28293240 | ||
| Retinoid-Induced Apoptosis and Sp1 Cleavage Occur Independently of Transcription and Require Caspase Activation | Q28379199 | ||
| Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome | Q28587895 | ||
| Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis | Q28610843 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE | Q29619356 | ||
| The Fas death factor | Q29620461 | ||
| Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution | Q33882237 | ||
| Does amalgam affect the immune system? A controversial issue | Q34059433 | ||
| Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone | Q34255110 | ||
| Autoantibodies in the diagnosis of systemicrheumatic diseases | Q34299389 | ||
| Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
| Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes | Q34618445 | ||
| Clonal analysis of the anti-DNA repertoire of murine B lymphocytes | Q34619539 | ||
| The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes | Q35589277 | ||
| Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation | Q35822538 | ||
| The autoantigen-binding B cell repertoires of normal and of chronically graft-versus-host-diseased mice | Q36352742 | ||
| Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice | Q36362973 | ||
| Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes | Q36363024 | ||
| DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis | Q36365577 | ||
| Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death | Q36366579 | ||
| Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis | Q36367200 | ||
| Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus | Q36376850 | ||
| Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming | Q36377451 | ||
| Association of Phosphorylated Serine/Arginine (SR) Splicing Factors With The U1–Small Ribonucleoprotein (snRNP) Autoantigen Complex Accompanies Apoptotic Cell Death | Q36400294 | ||
| Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition | Q37714426 | ||
| Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus | Q37722431 | ||
| Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes | Q38201550 | ||
| Fas and Fas ligand: lpr and gld mutations | Q40398275 | ||
| An evolutionary perspective on apoptosis. | Q40723583 | ||
| Negative selection of lymphocytes | Q40807431 | ||
| Life, death, and the pursuit of apoptosis. | Q40942974 | ||
| Protein degradation or regulation: Ub the judge | Q40970389 | ||
| Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review | Q40985416 | ||
| Degradation of topoisomerase IIalpha during adenovirus E1A-induced apoptosis is mediated by the activation of the ubiquitin proteolysis system | Q41159640 | ||
| Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. | Q41375803 | ||
| Signaling thresholds and interclonal competition in preimmune B-cell selection | Q41492235 | ||
| Self antigens and epitope spreading in systemic autoimmunity | Q41564944 | ||
| Apoptosis in the rheumatic diseases | Q41640058 | ||
| Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis | Q41968463 | ||
| Apoptotic keratin bodies as autoantigen causing the production of IgM-anti-keratin intermediate filament autoantibodies | Q42487323 | ||
| Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus | Q43506001 | ||
| The regulation of anoikis: MEKK-1 activation requires cleavage by caspases | Q46102806 | ||
| Malaria and macrophage function in Africans: a possible link with autoimmune disease? | Q46506546 | ||
| Heterogenous nuclear RNP C1 and C2 core proteins are targets for an autoantibody found in the serum of a patient with systemic sclerosis and psoriatic arthritis | Q57752790 | ||
| P433 | issue | 7 | |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 1152-1160 | |
| P577 | publication date | 1998-07-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens | |
| P478 | volume | 41 |
| Q84403635 | A case of ANCA-associated vasculitis with glomerular eosinophilic infiltration: a possible pathogenic implication |
| Q35134487 | Advances in B-cell epitope analysis of autoantigens in connective tissue diseases |
| Q35798719 | Altered autoantigen structure in Sjögren's syndrome: implications for the pathogenesis of autoimmune tissue damage |
| Q28347243 | Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE) |
| Q36553578 | Anti-neutrophil cytoplasmic autoantibodies: a renewed paradigm in periodontal disease pathogenesis? |
| Q36272782 | Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases |
| Q40718359 | Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ |
| Q36535200 | Apoptosis and autoimmunity: when apoptotic cells break their silence. |
| Q34317778 | Apoptosis of skeletal muscle cells and the pathogenesis of myositis: a perspective |
| Q74455322 | Apoptotic U1-70 kd is antigenically distinct from the intact form of the U1-70-kd molecule |
| Q83339044 | Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus |
| Q24804038 | Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease |
| Q35600096 | Autoimmune disorders: a concept of treatment based on mechanisms of disease |
| Q33976592 | Autoimmunity. Thoughts for the millennium |
| Q36974300 | B cells in glomerulonephritis: focus on lupus nephritis. |
| Q77567407 | Candidate T cell epitopes of the human La/SSB autoantigen |
| Q28218204 | Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders |
| Q33964330 | Caspase-dependent cleavage of nucleic acids |
| Q40650525 | Caspase-mediated cleavage of the U snRNP-associated Sm-F protein during apoptosis. |
| Q42836117 | Caspase-mediated cleavage of the exosome subunit PM/Scl-75 during apoptosis |
| Q31825208 | Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K protein |
| Q36375304 | Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity |
| Q77855089 | Coeliac disease and secondary autoimmunity |
| Q48013277 | Concomitant early appearance of anti-ribonucleoprotein and anti-nucleosome antibodies in lupus prone mice |
| Q24806787 | Death, autoantigen modifications, and tolerance |
| Q36010142 | Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice |
| Q44541039 | Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice |
| Q40942556 | Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti-beta2-glycoprotein I antibodies |
| Q40370028 | Detection of apoptosis-specific autoantibodies directed against granzyme B-induced cleavage fragments of the SS-B (La) autoantigen in sera from patients with primary Sjögren's syndrome. |
| Q80335455 | Dysregulation of apoptosis as mechanism supporting the induction of autoimmunity |
| Q46616063 | Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice |
| Q39675520 | Effects of type II collagen epitope carbamylation and citrullination in human leucocyte antigen (HLA)-DR4(+) monozygotic twins discordant for rheumatoid arthritis. |
| Q35674181 | Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis |
| Q34736496 | Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences |
| Q24800835 | Fragmentation of Golgi complex and Golgi autoantigens during apoptosis and necrosis |
| Q33195266 | Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa |
| Q24290327 | Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis |
| Q37722745 | High-Resolution Analysis of Antibodies to Post-Translational Modifications Using Peptide Nanosensor Microarrays. |
| Q36371257 | Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells |
| Q44210319 | Human autologous mixed lymphocyte reaction as an in vitro model for autoreactivity to apoptotic antigens |
| Q33902693 | Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen |
| Q36494607 | IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice |
| Q44062271 | Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay |
| Q36497940 | Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas |
| Q57350796 | Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families |
| Q42025177 | Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia |
| Q44250397 | Induction of cell death by sera from patients with acute brain injury as a mechanism of production of autoantibodies. |
| Q28481493 | Inflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complex |
| Q54389013 | Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis |
| Q41848357 | Inhibitors of MAPK pathway ERK1/2 or p38 prevent the IL-1{beta}-induced up-regulation of SRP72 autoantigen in Jurkat cells. |
| Q35215786 | LEDGF/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis |
| Q36677012 | Lessons for lupus from tumour necrosis factor blockade |
| Q33964319 | Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules |
| Q36751110 | Mapping epitopes of U1-70K autoantibodies at single-amino acid resolution |
| Q28236216 | Mixed connective tissue disease |
| Q36985980 | Multiplex giant magnetoresistive biosensor microarrays identify interferon-associated autoantibodies in systemic lupus erythematosus |
| Q34430999 | Myositis-specific autoantibodies: overview and recent developments |
| Q35661798 | Neo-epitopes are required for immunogenicity of the La/SS-B nuclear antigen in the context of late apoptotic cells |
| Q33312931 | Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons |
| Q43772911 | Novel fragments of the Sj�gren's syndrome autoantigens ?-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death |
| Q34629136 | Novel strategy in lupus therapy: from the peptide P140 to Lupuzor™ |
| Q34334379 | Nuclear apoptotic changes: an overview |
| Q37038484 | Pathophysiology of cutaneous lupus erythematosus |
| Q82397647 | Perforin level in CD4+ T cells from patients with systemic lupus erythematosus |
| Q37772795 | Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies. |
| Q34601748 | Proteomics technologies for the study of autoimmune disease |
| Q35636552 | Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement |
| Q34004618 | Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity |
| Q43800695 | Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: Implications for systemic autoimmunity |
| Q38299138 | Sequencing the functional antibody repertoire--diagnostic and therapeutic discovery |
| Q34308955 | Serological analysis of SEREX-defined medullary breast carcinoma-associated antigens. |
| Q37622471 | Serum autoantibodies as biomarkers for early cancer detection |
| Q37311012 | Silica, apoptosis, and autoimmunity |
| Q36084984 | Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies |
| Q43772895 | Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies |
| Q35589560 | T-helper cell tolerance to ubiquitous nuclear antigens |
| Q47329854 | Testing for anti-nucleosome antibodies in daily practice: a monocentric evaluation in 1696 patients |
| Q28291832 | The 72-kDa component of signal recognition particle is cleaved during apoptosis |
| Q28140527 | The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies |
| Q34779998 | The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases |
| Q34229325 | The anti-Sm immune response in autoimmunity and cell biology |
| Q42695851 | The antibody repertoire of colorectal cancer. |
| Q73540367 | The fate of U1 snRNP during anti-Fas induced apoptosis: specific cleavage of the U1 snRNA molecule |
| Q35089751 | The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line |
| Q80810942 | The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis |
| Q38206945 | The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved |
| Q34442173 | The pathogenesis of autoimmune diseases |
| Q35580535 | The role of jo-1 in the immunopathogenesis of polymyositis: Current hypotheses |
| Q30429149 | The role of nucleotides in apoptotic cell clearance: implications for disease pathogenesis |
| Q41956989 | Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus. |
| Q35045914 | Triggers for anti-chromatin autoantibody production in SLE. |
| Q36491988 | Tumor-associated antigen arrays for the serological diagnosis of cancer |
| Q36676995 | Ultraviolet light and cutaneous lupus |
| Q47097183 | Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer |
Search more.